Recital 7, Regulation (EU) 2024/324

In forcesince 19 Jan 2024

For the active substances benzovindiflupyr, bromuconazole, cyflufenamid, fluopyram, lambda-cyhalothrin and metsulfuron-methyl, the risk assessment pursuant to Article 11 of Implementing Regulation (EU) No 844/2012 has not yet been finalised by the respective rapporteur Member States.

  • celex=32012R0844